我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

诊断心力衰竭生化标志物的研究进展(PDF)

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2011年第5期
页码:
687-690
栏目:
综述
出版日期:
2011-10-25

文章信息/Info

Title:
-
作者:
李昌义 综述; 金 炜 审校
上海交通大学附属上海市第一人民医院心内科，上海 200080
Author(s):
-
关键词:
生化标志物; 心力衰竭; 诊断
Keywords:
-
分类号:
R541.61
DOI:
-
文献标识码:
A
摘要:
心力衰竭（HF）发生与发展的同时，会伴随着心肌负荷增加，心肌细胞损伤、凋亡，心肌细胞间质的纤维化，以及神经内分泌系统的激活等各种变化。这些变化可通过血清学检测HF的生化标志物了解HF的进展程度，指导HF的治疗。本文对HF的生化标志物进行了综述。
Abstract:
-

参考文献/References

[1]刘 勇,刘怡辰.心力衰竭的治疗、评价和展望[J].心脏杂志,20011,23(2):274-276.

[2]Braunwald E. Biomakers in heart failure[J].N Engl J Med,2008,358(20):2148-2159.

[3]刘晓艳,魏英杰.心脏生物标志物临床应用的进展[J].心脏杂志,2011,23(1):123-125,128.

[4]John G,Richard W,Kim M,et al. N-Terminal Pro-B-Type Natriuretic Peptide-Guided treatment for chronic heart failure[J].J Am Coll Cardiol,2010,55(1):53-60.

[5]Mueller T,Dieplinger B,Gegenhuber A,et al.Increased plasma concentrations of soluble ST2 are predictive for 1-year mortality in patients with acute destabilized heart failure[J].Clin Chem,2008,54(4):752-756.

[6]Januzzi JL Jr,Peacock WF,Maisel AS,et al. Measurement of the interleukin family member ST2 in patients with acute dyspnea:results from the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) study[J].J Am Coll Cardiol,2007,50(7):607-613.

[7]Villacorta H,Masetto AC,Mesquita ET.C-Reactive Protein:an inflammatory marker with prognostic value in patients with decompensated heart failure[J].Arq Bras Cardiol,2007,88(5):585-589.

[8]Tamariz L,Hare JM.Inflammatory cytokines in heart failure: roles in aetiology and utility as biomarkers[J].Eur Heart J,2010,31(7):768-770.

[9]Peacock WF,De Marco T,Fonarow GC,et al.Cardiac troponin and outcome in acute heart failure[J].N Engl J Med,2008,358(20):2117-2126.

[10]Lee HG,Bae WH,Kim SH,et al.The clinical usefulness of cardiac troponin i as a marker for severity in patients with congestive heart failure[J].Korean Circ J,2000,30(6):724-728.

[11]Chatzikyriakou SV,Tziakas DN,Chalikias GK,et al.Chronic heart failure patients with high collagen type I degradation marker levels bene?t more with ACE-inhibitor therapy[J].Eur J Pharmacol,2010,628(1-3):164-170.

[12]Tang WH, Shrestha K,Martin MG,et al.Clinical significance of endogenous vasoactive neurohormones in chronic systolic heart failure[J].J Card Fail,2010,16(8):635-640.

[13]Kazory A.Emergence of blood urea nitrogen as a biomarker of neurohormonal activation in heart failure[J].Am J Cardiol,2010,106（5）：694-700.

[14]Allen LA,Felker GM,Mehra MR,et al.Validation and potential mechanisms of red ］cell distribution width as a prognostic marker in heart failure[J].J Card Fail,2010, 16(3):230-238.

[15]De Boer RA,Lok D,Hillege JL,et al.Clinical and prognostic value of galectin-3,a novel fibrosis-associated biomarker.relation with clinical and biochemical correlates of heart failure[J].J Am Coll Cardiol,2010,55(10):1071-1079.

[16]Sasaki T,Takeishi Y,Suzuki S, et al.High serum level of neopterin is a risk factor of patients with heart failure[J].Int J Cardiol, 2010,145(2):318.

备注/Memo

备注/Memo:
收稿日期：2010-12-03.作者简介：李昌义，硕士生Email:lichangyi1212@sina.com
更新日期/Last Update: 2011-11-03